propiolactone and Malignant Melanoma

propiolactone has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Esteve-Puig, R; Kwong, A; Monshi, B; Moy, A; Murphy, R; Ortiz-Urda, S; Posch, C; Rappersberger, K; Sanlorenzo, M; Tsumura, A; Vujic, I; Vujic, M	1

Other Studies

1 other study(ies) available for propiolactone and Malignant Melanoma

Article	Year
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells. Oncotarget, 2016, Feb-09, Volume: 7, Issue:6 Topics: Apoptosis; Blotting, Western; Cell Proliferation; Enzyme Inhibitors; GTP Phosphohydrolases; Humans; Melanoma; Membrane Proteins; Molecular Targeted Therapy; Mutation; Propiolactone; RNA, Small Interfering; Thiolester Hydrolases; Tumor Cells, Cultured	2016

Article

Year

Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells.

Oncotarget, 2016, Feb-09, Volume: 7, Issue:6

Topics: Apoptosis; Blotting, Western; Cell Proliferation; Enzyme Inhibitors; GTP Phosphohydrolases; Humans; Melanoma; Membrane Proteins; Molecular Targeted Therapy; Mutation; Propiolactone; RNA, Small Interfering; Thiolester Hydrolases; Tumor Cells, Cultured

2016